Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.

Cobo-Calvo A, Sepúlveda M, d'Indy H, Armangué T, Ruiz A, Maillart E, Papeix C, Audoin B, Zephir H, Biotti D, Ciron J, Durand-Dubief F, Collongues N, Ayrignac X, Labauge P, Thouvenot E, Montcuquet A, Deschamps R, Solà-Valls N, Llufriu S, Blanco Y, de Seze J, Vukusic S, Saiz A, Marignier R; OFSEP Group; REEM Group.

J Neurol. 2019 Feb 7. doi: 10.1007/s00415-019-09215-1. [Epub ahead of print]

PMID:
30759286
2.

CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis.

Dhaeze T, Tremblay L, Lachance C, Peelen E, Zandee S, Grasmuck C, Bourbonnière L, Larouche S, Ayrignac X, Rébillard RM, Poirier J, Lahav B, Duquette P, Girard M, Moumdjian R, Bouthillier A, Larochelle C, Prat A.

Cell Mol Immunol. 2019 Jan 11. doi: 10.1038/s41423-018-0198-5. [Epub ahead of print]

PMID:
30635649
3.

Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.

Cobo-Calvo A, Sepúlveda M, d'Indy H, Armangué T, Ruiz A, Maillart E, Papeix C, Audoin B, Zephir H, Biotti D, Ciron J, Durand-Dubief F, Collongues N, Ayrignac X, Labauge P, Thouvenot E, Montcuquet A, Deschamps R, Solà-Valls N, Llufriu S, Blanco Y, de Seze J, Vukusic S, Saiz A, Marignier R; OFSEP Group; REEM Group.

J Neurol. 2019 Jan 3. doi: 10.1007/s00415-018-9160-9. [Epub ahead of print] Erratum in: J Neurol. 2019 Feb 7;:.

PMID:
30607536
4.

Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases.

Codjia P, Ayrignac X, Carra-Dalliere C, Cohen M, Charif M, Lippi A, Collongues N, Corti L, De Seze J, Lebrun C, Vukusic S, Durand-Dubief F, Labauge P; SFSEP and OFSEP.

Mult Scler Relat Disord. 2018 Dec 18;28:109-116. doi: 10.1016/j.msard.2018.12.022. [Epub ahead of print]

PMID:
30592992
5.

Optic chiasm and oculomotor nerves involvement in active multiple sclerosis.

Carra-Dalliere C, Menjot de Champfleur N, Ayrignac X, Labauge P.

J Neuroradiol. 2018 Nov 10. pii: S0150-9861(18)30254-2. doi: 10.1016/j.neurad.2018.10.007. [Epub ahead of print] No abstract available.

PMID:
30423382
6.

The coexistence of recurrent cerebral tumefactive demyelinating lesions with longitudinally extensive transverse myelitis and demyelinating neuropathy.

Ciron J, Carra-Dallière C, Ayrignac X, Neau JP, Maubeuge N, Labauge P.

Mult Scler Relat Disord. 2019 Jan;27:223-225. doi: 10.1016/j.msard.2018.11.002. Epub 2018 Nov 3.

PMID:
30414563
7.

Measurement of magnetization transfer ratio (MTR) from cervical spinal cord: Multicenter reproducibility and variability.

Combès B, Monteau L, Bannier E, Callot V, Labauge P, Ayrignac X, Carra Dallière C, Pelletier J, Maarouf A, de Seze J, Collongues N, Barillot C, Edan G, Ferré JC, Kerbrat A; EMISEP study group.

J Magn Reson Imaging. 2018 Oct 22. doi: 10.1002/jmri.26537. [Epub ahead of print]

PMID:
30350328
8.

Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.

Nadjar Y, Hütter-Moncada AL, Latour P, Ayrignac X, Kaphan E, Tranchant C, Cintas P, Degardin A, Goizet C, Laurencin C, Martzolff L, Tilikete C, Anheim M, Audoin B, Deramecourt V, De Gaillarbois TD, Roze E, Lamari F, Vanier MT, Héron B.

Orphanet J Rare Dis. 2018 Oct 1;13(1):175. doi: 10.1186/s13023-018-0913-4.

9.

Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia: An MRI Study of 16 French Cases.

Codjia P, Ayrignac X, Mochel F, Mouzat K, Carra-Dalliere C, Castelnovo G, Ellie E, Etcharry-Bouyx F, Verny C, Belliard S, Hannequin D, Marelli C, Nadjar Y, Le Ber I, Dorboz I, Samaan S, Boespflug-Tanguy O, Lumbroso S, Labauge P.

AJNR Am J Neuroradiol. 2018 Sep;39(9):1657-1661. doi: 10.3174/ajnr.A5744. Epub 2018 Aug 16.

PMID:
30115677
10.

Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patients.

Mekinian A, Maisonobe L, Boukari L, Melenotte C, Terrier B, Ayrignac X, Schleinitz N, Sène D, Hamidou M, Konaté A, Guilpain P, Abisror N, Ghrenassia E, Lachenal F, Cevallos R, Roos-Weil R, Du LTH, Lhote F, Larroche C, Bergmann JF, Humbert S, Fraison JB, Piette JC, Guillevin L, Dhote R, Amoura Z, Haroche J, Fain O.

Medicine (Baltimore). 2018 Jul;97(30):e11413. doi: 10.1097/MD.0000000000011413.

11.

Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.

Renard D, Tatu L, Collombier L, Wacongne A, Ayrignac X, Charif M, Boukriche Y, Chiper L, Fourcade G, Azakri S, Gaillard N, Mercier E, Lehmann S, Thouvenot E.

J Alzheimers Dis. 2018;64(4):1113-1121. doi: 10.3233/JAD-180269.

PMID:
30010128
12.

Primary brain calcification: an international study reporting novel variants and associated phenotypes.

Ramos EM, Carecchio M, Lemos R, Ferreira J, Legati A, Sears RL, Hsu SC, Panteghini C, Magistrelli L, Salsano E, Esposito S, Taroni F, Richard AC, Tranchant C, Anheim M, Ayrignac X, Goizet C, Vidailhet M, Maltete D, Wallon D, Frebourg T, Pimentel L, Geschwind DH, Vanakker O, Galasko D, Fogel BL, Innes AM, Ross A, Dobyns WB, Alcantara D, O'Driscoll M, Hannequin D, Campion D; French PFBC study group, Oliveira JR, Garavaglia B, Coppola G, Nicolas G.

Eur J Hum Genet. 2018 Oct;26(10):1462-1477. doi: 10.1038/s41431-018-0185-4. Epub 2018 Jun 28.

PMID:
29955172
13.

Focal and diffuse cervical spinal cord damage in patients with early relapsing-remitting MS: A multicentre magnetisation transfer ratio study.

Combès B, Kerbrat A, Ferré JC, Callot V, Maranzano J, Badji A, Le Page E, Labauge P, Ayrignac X, Carra Dallière C, de Champfleur NM, Pelletier J, Maarouf A, de Seze J, Collongues N, Brassat D, Durand-Dubief F, Barillot C, Bannier E, Edan G; EMISEP Study Group.

Mult Scler. 2018 Jun 1:1352458518781999. doi: 10.1177/1352458518781999. [Epub ahead of print]

PMID:
29909771
14.

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.

Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, Ciron J, Collongues N, Brassat D, Cotton F, Papeix C, Durand-Dubief F, Laplaud D, Deschamps R, Cohen M, Biotti D, Ayrignac X, Tilikete C, Thouvenot E, Brochet B, Dulau C, Moreau T, Tourbah A, Lebranchu P, Michel L, Lebrun-Frenay C, Montcuquet A, Mathey G, Debouverie M, Pelletier J, Labauge P, Derache N, Coustans M, Rollot F, De Seze J, Vukusic S, Marignier R; OFSEP and NOMADMUS Study Group.

Neurology. 2018 May 22;90(21):e1858-e1869. doi: 10.1212/WNL.0000000000005560. Epub 2018 Apr 25.

PMID:
29695592
15.

Atypical inflammatory demyelinating lesions and atypical multiple sclerosis.

Ayrignac X, Carra-Dallière C, Labauge P.

Rev Neurol (Paris). 2018 Jun;174(6):408-418. doi: 10.1016/j.neurol.2018.03.007. Epub 2018 Apr 16. Review.

PMID:
29673573
16.

Late activity rebound in non-active multiple sclerosis: A rare event.

Corti L, Ayrignac X, Carra Dalliere C, Charif M, de Sèze J, Biotti D, Ciron J, Labauge P.

Mult Scler. 2018 Oct;24(12):1649-1650. doi: 10.1177/1352458518765670. Epub 2018 Mar 13. No abstract available.

PMID:
29533160
17.

Psychological processes associated with insomnia in patients with multiple sclerosis.

Schellaert V, Labauge P, Lebrun C, Maudarbocus KH, Bernard J, Blache JB, Ayrignac X, Carra-Dallière C, Gely-Nargeot MC, Bayard S.

Sleep. 2018 Mar 1;41(3). doi: 10.1093/sleep/zsy002.

PMID:
29309702
18.

Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.

Renard D, Collombier L, Demattei C, Wacongne A, Charif M, Ayrignac X, Azakri S, Gaillard N, Boudousq V, Lehmann S, Menjot de Champfleur N, Thouvenot E.

J Alzheimers Dis. 2018;61(3):1107-1117. doi: 10.3233/JAD-170843.

PMID:
29254099
19.

Mechanical Thrombectomy for Minor and Mild Stroke Patients Harboring Large Vessel Occlusion in the Anterior Circulation: A Multicenter Cohort Study.

Dargazanli C, Arquizan C, Gory B, Consoli A, Labreuche J, Redjem H, Eker O, Decroix JP, Corlobé A, Mourand I, Gaillard N, Ayrignac X, Charif M, Duhamel A, Labeyrie PE, Riquelme C, Ciccio G, Smajda S, Desilles JP, Gascou G, Lefèvre PH, Mantilla-García D, Cagnazzo F, Coskun O, Mazighi M, Riva R, Bourdain F, Labauge P, Rodesch G, Obadia M, Bonafé A, Turjman F, Costalat V, Piotin M, Blanc R, Lapergue B; ETIS REGISTRY Investigators.

Stroke. 2017 Dec;48(12):3274-3281. doi: 10.1161/STROKEAHA.117.018113. Epub 2017 Oct 31.

PMID:
29089458
20.

Favorable revascularization therapy in patients with ASPECTS ≤ 5 on DWI in anterior circulation stroke.

Mourand I, Abergel E, Mantilla D, Ayrignac X, Sacagiu T, Eker OF, Gascou G, Dargazanli C, Riquelme C, Moynier M, Bonafé A, Arquizan C, Costalat V.

J Neurointerv Surg. 2018 Jan;10(1):5-9. doi: 10.1136/neurintsurg-2017-013358. Epub 2017 Oct 27.

PMID:
29079663
21.

Is impaired cerebral vasoreactivity an early marker of cognitive decline in multiple sclerosis patients?

Metzger A, Le Bars E, Deverdun J, Molino F, Maréchal B, Picot MC, Ayrignac X, Carra C, Bauchet L, Krainik A, Labauge P, Menjot de Champfleur N.

Eur Radiol. 2018 Mar;28(3):1204-1214. doi: 10.1007/s00330-017-5068-5. Epub 2017 Oct 12.

PMID:
29026971
22.

Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France.

Biotti D, Bonneville F, Tournaire E, Ayrignac X, Dallière CC, Mahieu L, Vignal C, Dulau C, Brochet B, Ruet A, Ouallet JC, Gout O, Heran F, Menjot de Champfleur N, Tourdias T, Deneve M, Labauge P, Deschamps R.

J Neurol. 2017 Oct;264(10):2173-2175. doi: 10.1007/s00415-017-8615-8. Epub 2017 Sep 15. No abstract available.

PMID:
28914353
23.

A Case Report of Solitary Sclerosis: This is Really Multiple Sclerosis.

Lebrun C, Cohen M, Mondot L, Ayrignac X, Labauge P.

Neurol Ther. 2017 Dec;6(2):259-263. doi: 10.1007/s40120-017-0082-8. Epub 2017 Aug 24.

24.

MRI volumetric morphometry in vascular parkinsonism.

Dunet V, Deverdun J, Charroud C, Le Bars E, Molino F, Menjot de Champfleur S, Maury F, Charif M, Ayrignac X, Labauge P, Castelnovo G, Pinna F, Bonafe A, Geny C, Menjot de Champfleur N.

J Neurol. 2017 Jul;264(7):1511-1519. doi: 10.1007/s00415-017-8561-5. Epub 2017 Jul 1.

PMID:
28669119
25.

Brain Calcifications in Adult-Onset Genetic Leukoencephalopathies: A Review.

Ayrignac X, Nicolas G, Carra-Dallière C, Hannequin D, Labauge P.

JAMA Neurol. 2017 Aug 1;74(8):1000-1008. doi: 10.1001/jamaneurol.2017.1062. Review.

PMID:
28628708
26.

Author response: Mystery Case: CSF-1R mutation is a cause of intracranial cerebral calcifications, cysts, and leukoencephalopathy.

Ayrignac X.

Neurology. 2017 May 16;88(20):1978. doi: 10.1212/WNL.0000000000003949. No abstract available.

PMID:
28507264
27.

Intracranial stenting after the Wingspan withdrawal in France: Clinical experience using a low profile coronary stent.

Dargazanli C, Mantilla D, Wiesspeiner U, Ayrignac X, Costalat V.

J Neuroradiol. 2017 Mar;44(2):165-167. doi: 10.1016/j.neurad.2016.12.007. Epub 2017 Feb 4. No abstract available.

PMID:
28168991
28.

TREX1 Mutation in Leukodystrophy with Calcifications and Persistent Gadolinium-Enhancement.

Carra-Dalliere C, Ayrignac X, Prieto-Morin C, Girard P, Tournier-Lasserve E, Labauge P.

Eur Neurol. 2017;77(3-4):113-114. doi: 10.1159/000455095. Epub 2016 Dec 24. No abstract available.

PMID:
28013302
29.

Mystery Case: CSF-1R mutation is a cause of intracranial cerebral calcifications, cysts, and leukoencephalopathy.

Ayrignac X, Mouzat K, Magnin E, Berger E, Carra-Dallière C, Lumbroso S, Labauge P.

Neurology. 2016 Nov 29;87(22):e262-e263. No abstract available. Erratum in: Neurology. 2017 May 16;88(20):1979. Neurology. 2017 Sep 1;:.

PMID:
27895249
30.

Paraplegia related to solitary lesion of the cervicomedullary junction.

Taieb G, Ayrignac X, Carra-Dalliere C, Labauge P.

Acta Neurol Belg. 2017 Jun;117(2):545-546. doi: 10.1007/s13760-016-0711-5. Epub 2016 Oct 18. No abstract available.

PMID:
27757810
31.

Study of subclinical ocular motor disorders by video oculography in patients with clinically isolated syndromes.

Castelnovo G, Ferraro A, Ayrignac X, Renard D, Carra-Dalliere C, Labauge P, Thouvenot E, Jeanjean EL.

Mult Scler Relat Disord. 2016 Sep;9:118-20. doi: 10.1016/j.msard.2016.07.010. Epub 2016 Jul 19. No abstract available.

PMID:
27645356
32.

The wide POLG-related spectrum: An integrated view.

Béreau M, Anheim M, Echaniz-Laguna A, Magot A, Verny C, Goideau-Sevrain M, Barth M, Amati-Bonneau P, Allouche S, Ayrignac X, Bédat-Millet AL, Guyant-Maréchal L, Kuntzer T, Ochsner F, Petiot P, Vial C, Omer S, Sole G, Taieb G, Carvalho N, Tio G, Kremer S, Acquaviva-Bourdain C, de Camaret BM, Tranchant C.

J Neurol Sci. 2016 Sep 15;368:70-6. doi: 10.1016/j.jns.2016.06.062. Epub 2016 Jun 29. No abstract available.

PMID:
27538604
33.

Mini-Exome Coupled to Read-Depth Based Copy Number Variation Analysis in Patients with Inherited Ataxias.

Marelli C, Guissart C, Hubsch C, Renaud M, Villemin JP, Larrieu L, Charles P, Ayrignac X, Sacconi S, Collignon P, Cuntz-Shadfar D, Perrin L, Benarrosh A, Degardin A, Lagha-Boukbiza O, Mutez E, Carlander B, Morales RJ, Gonzalez V, Carra-Dalliere C, Azakri S, Mignard C, Ollagnon E, Pageot N, Chretien D, Geny C, Azulay JP, Tranchant C, Claustres M, Labauge P, Anheim M, Goizet C, Calvas P, Koenig M.

Hum Mutat. 2016 Dec;37(12):1340-1353. doi: 10.1002/humu.23063. Epub 2016 Sep 2.

PMID:
27528516
34.

Cognitive Impairment and Basal Ganglia Functional Connectivity in Vascular Parkinsonism.

Dunet V, Deverdun J, Charroud C, Le Bars E, Molino F, Menjot de Champfleur S, Maury F, Charif M, Ayrignac X, Labauge P, Castelnovo G, Pinna F, Bonafe A, Geny C, Menjot de Champfleur N.

AJNR Am J Neuroradiol. 2016 Dec;37(12):2310-2316. Epub 2016 Jul 14.

35.

CSF1R-related leukoencephalopathy mimicking primary progressive multiple sclerosis.

Prieto-Morin C, Ayrignac X, Ellie E, Tournier-Lasserve E, Labauge P.

J Neurol. 2016 Sep;263(9):1864-5. doi: 10.1007/s00415-016-8197-x. Epub 2016 Jun 17. No abstract available.

PMID:
27314966
36.

Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.

Davion JB, Cambron M, Duhin E, Chouraki A, Lacour A, Labauge P, Carra C, Ayrignac X, Vermersch P.

J Neurol. 2016 Jul;263(7):1361-3. doi: 10.1007/s00415-016-8144-x. Epub 2016 May 9.

PMID:
27159986
37.

High CD3+ Cells in Intracranial Thrombi Represent a Biomarker of Atherothrombotic Stroke.

Dargazanli C, Rigau V, Eker O, Riquelme Bareiro C, Machi P, Gascou G, Arquizan C, Ayrignac X, Mourand I, Corlobé A, Lobotesis K, Molinari N, Costes V, Bonafé A, Costalat V.

PLoS One. 2016 May 6;11(5):e0154945. doi: 10.1371/journal.pone.0154945. eCollection 2016.

38.

Posterior fossa involvement in the diagnosis of adult-onset inherited leukoencephalopathies.

Ayrignac X, Boutiere C, Carra-Dalliere C, Labauge P.

J Neurol. 2016 Dec;263(12):2361-2368. Epub 2016 Apr 28. Review.

PMID:
27126452
39.

Endovascular Management of Tandem Occlusion Stroke Related to Internal Carotid Artery Dissection Using a Distal to Proximal Approach: Insight from the RECOST Study.

Marnat G, Mourand I, Eker O, Machi P, Arquizan C, Riquelme C, Ayrignac X, Bonafé A, Costalat V.

AJNR Am J Neuroradiol. 2016 Jul;37(7):1281-8. doi: 10.3174/ajnr.A4752. Epub 2016 Mar 10.

40.

Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.

Renard D, Wacongne A, Ayrignac X, Charif M, Fourcade G, Azakri S, Le Floch A, Bouly S, Marelli C, Arquizan C, Hirtz C, Gabelle A, Thouvenot E, Lehmann S.

J Alzheimers Dis. 2016;50(3):759-764. doi: 10.3233/JAD-150621.

41.

Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease.

Ayrignac X, Menjot de Champfleur N, Menjot de Champfleur S, Carra-Dallière C, Deverdun J, Corlobe A, Labauge P.

Eur J Neurol. 2016 Jun;23(6):995-1000. doi: 10.1111/ene.12931. Epub 2016 Jan 4.

PMID:
26727496
42.

Low Signals on T2* and SWI Sequences in Patients with MS with Progressive Multifocal Leukoencephalopathy.

Labauge P, Carra-Dalliere C, Ayrignac X, Menjot de Champfleur N.

AJNR Am J Neuroradiol. 2016 Feb;37(2):E11. doi: 10.3174/ajnr.A4632. Epub 2015 Dec 3. No abstract available.

43.

Favorable Bridging Therapy Based on DWI-FLAIR Mismatch in Patients with Unclear-Onset Stroke.

Mourand I, Milhaud D, Arquizan C, Lobotesis K, Schaub R, Machi P, Ayrignac X, Eker OF, Bonafé A, Costalat V.

AJNR Am J Neuroradiol. 2016 Jan;37(1):88-93. doi: 10.3174/ajnr.A4574. Epub 2015 Nov 5.

44.

Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy.

Carra-Dalliere C, Menjot de Champfleur N, Deverdun J, Ayrignac X, Nerrant E, Makinson A, Casanova ML, Labauge P.

J Neuroradiol. 2016 Feb;43(1):6-10. doi: 10.1016/j.neurad.2015.08.001. Epub 2015 Oct 23.

PMID:
26475668
45.

Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis.

Flaire A, Carra-Dalliere C, Ayrignac X, Blanc P, Labauge P.

Acta Neurol Belg. 2016 Mar;116(1):99-100. doi: 10.1007/s13760-015-0506-0. Epub 2015 Jul 4. No abstract available.

PMID:
26141739
46.

Quantitative susceptibility mapping in superficial hemosiderosis of the central nervous system.

Dargazanli C, Deverdun J, Lionnet C, Michau S, Ozluk E, Corlobé A, Ayrignac X, Carra-Dallière C, Le Bars E, Labauge P, Bonafé A, Menjot de Champfleur N.

J Neuroradiol. 2015 Dec;42(6):370-2. doi: 10.1016/j.neurad.2015.04.007. Epub 2015 Jun 6. No abstract available.

PMID:
26054638
47.

Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.

Siri A, Carra-Dalliere C, Ayrignac X, Pelletier J, Audoin B, Pittion-Vouyovitch S, Debouverie M, Lionnet C, Viala F, Sablot D, Brassat D, Ouallet JC, Ruet A, Brochet B, Taillandier L, Bauchet L, Derache N, Defer G, Cabre P, de Seze J, Lebrun Frenay C, Cohen M, Labauge P.

J Neurol. 2015 Jul;262(7):1637-45. doi: 10.1007/s00415-015-7758-8. Epub 2015 May 1.

PMID:
25929666
48.

Quantitative susceptibility mapping suggests a paramagnetic effect in PML.

Carra-Dalliere C, Menjot de Champfleur N, Ayrignac X, Deverdun J, Labauge P.

Neurology. 2015 Apr 7;84(14):1501-2. doi: 10.1212/WNL.0000000000001455. No abstract available.

PMID:
25846998
49.

A novel autosomal dominant leukodystrophy with specific MRI pattern.

Corlobé A, Taithe F, Clavelou P, Pierre E, Carra-Dallière C, Ayrignac X, Mouzat K, Lumbroso S, Menjot de Champfleur N, Koenig M, Boespflug-Tanguy O, Labauge P.

J Neurol. 2015;262(4):988-91. doi: 10.1007/s00415-015-7660-4. Epub 2015 Feb 17.

PMID:
25683759
50.

Solitary sclerosis: Experience from three French tertiary care centres.

Cohen M, Lebrun C, Ayrignac X, Labauge P, Assouad R.

Mult Scler. 2015 Aug;21(9):1216. doi: 10.1177/1352458515570405. Epub 2015 Feb 13. No abstract available.

PMID:
25680988

Supplemental Content

Loading ...
Support Center